Metabolic syndrome X is a low-grade systemic inflammatory condition with its origins in the perinatal period

Current Nutrition and Food Science

Volumn 3, Issue 4, 2007, Pages 277-295

  Das, Undurti N ^a  

^a UND LIFE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACETYLCHOLINE; ADIPONECTIN; ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; DOPAMINE; ENZYME; FATTY ACID SYNTHASE INHIBITOR; GLUCOSE; ICOSAPENTAENOIC ACID; INSULIN; INSULIN RECEPTOR; LEPTIN; LONG CHAIN FATTY ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE; NEUROTRANSMITTER; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; SEROTONIN; TRANS FATTY ACID;

ABDOMINAL OBESITY; ADIPOSE TISSUE; BRAIN DEVELOPMENT; BRAIN GROWTH; CALORIC INTAKE; DISEASE MODEL; ENZYME ACTIVITY; FATTY ACID METABOLISM; HORMONE ACTION; HUMAN; INFLAMMATION; LACTATION; MATERNAL NUTRITION; METABOLIC SYNDROME X; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERINATAL PERIOD; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; SYNAPTOGENESIS; ZONA INCERTA;

EID: 36248977186     PISSN: 15734013     EISSN: None     Source Type: Journal    
DOI: 10.2174/1573401310703040277     Document Type: Review

References (376)

1. McKeigue P, Sevak L. Coronary heart disease in South Asian Communities. London: Health Education Authority, 1994.
2. Hansen BC, Jen K-L, Schwartz J. Changes in insulin responses and binding in adipocytes from monkeys with obesity progressing to diabetes. Int J Obes 1988; 12: 391-401.
3. Das UN. Exercise and inflammation. Eur Heart J 2006; 27: 1385-86.
4. Das UN. Anti-inflammatory nature of exercise. Nutrition 2004; 20: 323-326.
5. Yamashita N, Hoshida S, Otsu K, et al. Exercise provides direct biphasic Cardioprotection via manganese superoxide dismutase activation. J Exp Med 1999; 189: 1699-1706.
6. Wang XL, Adachi T, Sim AS, Wilcken DE. Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler Thromb Vasc Biol 1998; 18: 1915-21.
7. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA 2005; 293:1861-67.
8. Bjorntorp P. Adipose tissue distribution and function. Int J Obes 1991; 15 (Suppl 2): 67-81.
9. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72:1150-62.
10. Pederson O, Hjollund E, Lindskov HO. Insulin-binding and action on fat cells from young healthy females and males. Am J Physiol 1982; 243: E158-E167.
11. Rebuffe-Scrive M, Enk L, Crona N, Lonnroth P, Abrahamsson L, Smith U, Bjorntorp P. Fat cell metabolism in different regions in women. Effect of menstrual cycle, pregnancy, and lactation. J Clin Invest 1985; 75: 1973-1976.
12. Orel M, Lichnovska R, Gwozdziewiczova S, et al. Gender differences in tumor necrosis factor alpha and leptin secretion from subcutaneous and visceral fat tissue. Physiol Res 2004, 53:501-505.
13. Das UN. Sex differences in the number of adipose cells. XX vs. XY 2003; 1: 132-33.
14. Montague CI, Prins JB, Sanders L, et al. Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 1998; 47:1384-91
15. Vidal-Puig AJ, Considine RV, Jimenez-Linan M, et al. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997; 99:2416-22.
16. Ramos EJB, Xu Y, Romanova I, Middleton F, Chen C, Quinn I, Inui A, Das UN, Meguid MM. Is obesity an inflammatory disease? Surgery 2003; 134:329-335.
17. Das UN. Is obesity an inflammatory condition? Nutrition 2001; 17: 953-66.
18. Das UN. Obesity, metabolic syndrome X, and inflammation. Nutrition 2002; 18: 430-32.
19. Beckman M. Great balls of fat. Science 2006; 311: 1232-34.
20. Das UN. Aberrant expression of perilipins and 11-β-HSD-1 as molecular signatures of metabolic syndrome X in South East Asians. J Assoc Physicians India 2006; 54: 637-49.
21. Sinha S, Rathi M, Misra A, et al. Subclinical inflammation and soleus muscle intramyocellular lipids in healthy Asian Indian males. Clin Endocrinol (Oxf) 2005; 63: 350-55.
22. Das UN. Hypertension as a low-grade systemic inflammatory condition that has its origins in the perinatal period. J Assoc Physicians India 2006; 54: 133-42.
23. Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham coronary heart disease risk score. Circulation 2003; 108: 161-65.
24. van der Meer IM, de Maat MPM, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured as various sites in the arterial tree. The Rotterdam study. Stroke 2002; 33: 2750-2755.
25. Luc G, Bard J-M, Juhan-Vague I, et al. C-reactive protein, interleukins-6, and fibrinogen as predictors of coronary heart disease. The PRIME study. Arterioscler Thromb Vasc Biol 2003; 23: 1255-1261.
26. Engstrom G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgarde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003; 52: 2097-2101.
27. Moses, L. C-reactive protein-to screen or not to screen. N Engl J Med 2002; 347: 1615-1617.
28. Castell JV, Gomez-Lechon MJ, David M, Horano T, Kishimoto T, Heinrich PC. Recombinant human interleukins-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 1988; 232: 347-350.
29. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP. The relation of markers of inflammation to the development of glucose disorders in the elderly. Diabetes 2001; 50: 2384-2389.
30. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003; 107: 391-397.
31. Liu S, Manson JE, Buring JE, Stampfer MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentrations of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr 2002; 75:492-498.
32. Pepys MB, Hirshfiled GM. C-reactive protein: a crticial update. J Clin Invest 2003; 111: 1805-1812.
33. Griselli M, Herbert J, Hutchinson WL, Taylor KM, Sohail M, Krausz T, Pepys MB. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction. J Exp Med 1999; 190: 1733-1739.
34. Gill R, Kemp JA, Sabin C, Pepys MB, HumanC-reactive protein increases cerebral infarcit size after middle cerebral artery occlusion in adult rats. J Cereb Blood Flow Metab 2004; 24: 1214-1218.
35. Pepys MB, Hirschfield GM, Tennent GA, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006; 440: 1217-1221.
36. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Role of oxidative stress. Circulation 2002; 106: 2067-2072.
37. Kirwan JP, Krishnan RK, Weaver JA, Del Aguila LF, Evans WJ. Human aging is associated with altered TNF-α production dining hyperglycemia and hyperinsulinemia. Am J Physiol 2001; 281: E1137-E1143.
38. Lin Y, Rajala MW, Berger JP, Moller DE, Barzilai N, Scherer PE. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001; 276: 42077-42083.
39. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 2002; 39: 197-202.
40. Fernandez-Real JM, Vayreda M, Richart C, et al. Circulating interleukins 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab 2001; 86: 1154-1159.
41. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001; 38: 399-403.
42. Das UN. Clinical laboratory tools to diagnose inflammation. Adv Clin Chem 2006; 41: 189-229.
43. Hirschfield GM, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA, Pepys MB. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2005; 102: 8309-8314.
44. Brochu M, Tchernof A, Dionne IJ, et al. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women? J Clin Endocrinol Metab 2001; 86: 1020-1025.
45. Masuzaki H, Paterson J, Shinyama H, et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001; 294: 2166-2170.
46. Bujalska IJ, Kumar S, Hewison M, Stewart PM. Differentiation of adipose stromal cells: the roles of glucocorticoids and 11beta-hydroxysteroid dehydrogenase. Endocrinology 1999; 140:3188-3196.
47. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab 2002; 87:5630-5635.
48. Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier LJ, Permana PA. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle. Diabetologia 2004; 47:1088-1095.
49. Robitaille J, Brouillette C, Houde A, Despres JP, Tchernof A, Vohl MC. Molecular screening of the 11beta-HSD1 gene in men characterized by the metabolic syndrome. Obes Res 2004; 12:1570-1575.
50. Sandeep TC, Andrew F, Homer N, Andrews RC, Smith K, Walker BR. Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone. Diabetes 2005; 54:872-879.
51. Morton NM, Paterson JM, Masuzaki H, et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice. Diabetes 2004; 53:931-938.
52. Handoko K, Yang K, Strutt B, Khalil W, Killinger D. Insulin attenuates the stimulatory effects of tumor necrosis factor alpha on 11beta-hydroxysteroid dehydrogenase 1 in human adipose stromal cells. J Steroid Biochem Mol Biol 2000; 72:163-168.
53. Tomlinson JW, Moore J, Cooper MS, et al. Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology 2001; 142:1982-1989.
54. Han J, Thompson P, Beutler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway. J Exp Med 1990; 172:391-394.
55. Degawa- Yamauchi M, Moss KA, Bovenkerk JE, et al. Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 2005; 13:662-669.
56. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue. Relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes 2003; 52: 1779-1785.
57. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines. In vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527-E533.
58. Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003; 148: 657-662.
59. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-674.
60. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
61. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003; 361: 226-228.
62. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799-1804.
63. Sciacqua A, Candigliota M, Ceravolo R, et al. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Diabetes Care 2003; 26: 1673-1678.
64. Yatagai T, Nishida Y, Nagasaka S, et a. Relationship between exercise training-induced increase in insulin sensitivity and adiponectinemia in healthy men. Endocr J 2003; 50: 233-238.
65. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106: 1439-1441.
66. Soares AF, Guichardant M, Cozzone D, et al. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 2005; 38:882-889.
67. Das UN. Is metabolic syndrome X an inflammatory condition? Exp Biol Med 2002; 227: 989-997.
68. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000; 85: 2970-2973.
69. Mohanty P, Ghanim H, Hamouda W, Aljada A, Garg B, Dandona P. Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells. Am J Clin Nutr 2002; 75: 767-772.
70. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 2004; 279:30369-30374.
71. Lin Y, Berg AH, Iyengar P, et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 2005; 280:4617-4626.
72. Talior I, Yarkoni M, Bashan N, Eldar-Finkelman H. Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice. Am J Physiol Endocrinol Metab 2003; 285:E295-E302.
73. Fan J, Frey RS, Rahman A, Malik AB. Role of neutrophil NADPH oxidase in the mechanism of tumor necrosis factor-α-induced NF-kB activation and intercellular adhesion molecule-1 expression in endothelial cells. J Biol Chem 2002; 277: 3404-3411.
74. Hattori Y, Matsumura M, Kasai K. Vascular smooth muscle cell activation by C-reactive protein. Cardiovasc Res 2003; 58: 186-195.
75. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells. Circulation 2003; 107: 398-404.
76. Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114:1752-1761.
77. Fortuno A, San Jose G, Moreno MU, Beloqui O, Diez; J, Zalba G. Phagocytic NADPH oxidase overactivity underlies oxidative stress in metabolic syndrome. Diabetes 2006; 55:209-215.
78. Mohan IK and Das UN. Oxidant stress, anti-oxidants and nitric oxide in non-insulin dependent diabetes mellitus. Med Sci Res 1997; 25: 55-57.
79. Kumar KV and Das UN. Lipid peroxides and essential fatty acids in patients with coronary heart disease. J Nutr Med 1994; 4: 33-37.
80. Das UN, Kumar KV, Mohan IK. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 1994; 4: 149-155.
81. Kumar KV and Das UN. Are free radicals involved in the pathobiology of human essential hypertension? Free Radic Res Commun 1993; 19: 59-66.
82. Das UN. Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: Further discussion and some suggestions. Nutrition 2003; 19: 560-562.
83. Dandona P, Mohanty P, Ghanim H, et al. The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation, and protein carbonylation. J Clin Endocrinol Metab 2001; 86: 355-362.
84. Das UN. Folic acid says NO to vascular diseases. Nutrition 2003; 19: 686-692.
85. Barbato JE, Zuckerbraun BS, Overhaus M, Raman KG, Tzeng E. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome. Am J Physiol Heart Circ Physiol 2005; 289:H228-H236.
86. Lteif A, Mather K. Insulin resistance, metabolic syndrome and vascular diseases: Update on mechanistic linkages. Can J Cardiol 2004; 20 Suppl B: 66B-76B.
87. Jovinge S, Hamsten A, Tomvall P, et al. Evidence for a role of tumor necrosis factor alpha in disturbances of triglycerides and glucose metabolism predisposing to coronary heart disease. Metabolism 1998; 47: 113-118.
88. Corica F, Allegra A, Corsonello A, et al. Relationship between plasma leptin levels and the tumor necrosis factor alpha system in obese subjects. Int J Obes Metab Disord 1999; 23: 355-360.
89. Chu N-F, Spiegelman D, Rifai N, et al. Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes 2000; 24: 1085-1092.
90. Spieker LE, Sudano I, Hurlimann D, et al. High-density lipoprotein restores endothelial function in hypercholesterolemic men. Circulation 2002; 105: 1399-1402.
91. Li XA, Titlow WB, Jackson BA, Giltiay N, Nikolova-Karakashian M, Uittenbogaard A, Smart EJ. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J Biol Chem 2002; 277:11058-11063.
92. Denicola A, Batthyany C, Lissi E, et al. Diffusion of nitric oxide into low density lipoprotein. J Biol Chem 2002; 277: 932-936.
93. Ji Y, Diao J, Han Y, Huang Y, Bai H, Chen Q, Fan L, Ferro A. Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low-density lipoprotein. Atherosclerosis 2006; 188: 84-94.
94. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001; 17: 337-346.
95. Seshiah PN, Weber DS, Rocic P, Valppu L, Taniyama Y, Griendling KK, Angiotensin II stimulation of NAD(P)H oxidase activity. Circ Res 2002; 91: 406-413.
96. Furuhashi M, Ura N, Higashiura K, et al. Blockade of the remin-angiotensin system increases adiponectin concentrations in patients with essential hypertension. Hypertension 2003; 42: 76-81.
97. Zhang H, Zhang B, Tang BY, Chen YY, Zhu L, Shen YL. Angiotensin-converting enzyme inhibitors potentiate subthreshold preconditioning through NO and mitoK(ATP) channel. Sheng Li Xue Bao 2005; 57:453-460.
98. Das UN. Is insulin an anti-inflammatory molecule? Nutrition 2001; 17: 409-413.
99. Jeschke MG, Einspanier R, Klein D, et al. Insulin attenuates the systemic inflammatory response. Mol Med 2002; 8: 443-450.
100. Dandona P, Aljada A, Mohanty P. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 2062; 45: 924-930.
101. Otero M, Lago R, Gomez R, Lago F, Gomez-Reino JJ, Gualillo O. Leptin: a metabolic hormone that functions like a proinflammatory adipokine. Drugs News Perspect 2006; 19: 21-26.
102. Whincup PH, Gilg JA, Papacosta O, et al. Early evidence of ethnic differencess in cardiovascular risk: cross sectional comparison of British South Asian and white children. BMJ 2002; 324: 1-6.
103. Kalhan R, Puthawala K, Agarwal S, Amini SB, Kalhan SC. Altered lipid profile, leptin, insulin, and anthropometry in offspring of South Asian immigrants in the United States. Metabolism 2001; 50: 1197-1202.
104. Tomilinson JW, Moore J, Cooper MS, et al. Regulation of expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue: Tissue-specific induction by cytokines. Endocrinology 2001; 142: 1982-1989.
105. Gao F, Gao E, Yue T-L, et al. Nitric oxide mediates the anti-apoptotic effect of insulin in myocardial ischemia-reperfusion. The roles of P13-kinase, Akt, and endothelial nitric oxide synthase phosphorylation. Circulation 2002; 105: 1497-1502.
106. Das UN. Pathobiology of metabolic syndrome X in obese and non-obese South Asian Indians: Further discussion and some suggestions. Nutrition 2003; 19: 560-562.
107. Parsons TJ, Power C, Manor O. Fetal and early life growth and body mass index from birth to early adulthood in 1958 birth cohort: longitudinal study. BMJ 2001, 323: 1331-1335.
108. Singhal A, Wells J, Cole TJ, Fewtrell M, Lucas A. Programming lean body mass: a link between birth weight, obesity, and cardiovascular disease? Am J Clin Nutr 2003; 77: 726-730.
109. Dorner G, Plagemann A. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life. Horm Metab Res 1994; 26: 213-221.
110. Buchanan TA and Kjos SL. Gestational diabetes: risk or myth? J Clin Endocrinol Metab 1999; 84: 1854-1857.
111. Loos RJ, Beunen G, Fagard R, Derom C, Vlietinck R. Birth weight and body composition in young adult men-a prospective twin study. Int J Obes Relat Metab Disord 2001; 25: 1537-1545.
112. Loos RJ, Beunen G, Fagard R, Derom C, Vlietinck R. Birth weight and body composition in young women: a prospective twin study. Am J Clin Nutr 2002; 75: 676-682.
113. Grove KL, Smith MS, Ontogeny of the hypothalamic neuropeptide Y system. Physiol Behav 2003; 79: 47-63.
114. McMillen IC, Adam CL, Muhlhausler BS. Early origins of obesity: programming the appetite regulatory system. J Physiol 2005; 565: 9-17.
115. Davidowa H, Li Y, Plagemann A. Altered responses to orexigenic (AGRP, MCH) and anorexigenic (alpha-MSH, CART) neuropeptides of paraventricular hypothalamic neurons in early postnatally overfed rats. Eur J Neurosci 2003; 18: 613-621.
116. Fahrenkrog S, Harder T, Stolaczyk E, et al. Cross-fostering to diabetic rat dams affects early development of mediobasal hypothalamic nuclei regulating food intake, body weight, and metabolism. J Nutr 2004; 134: 648-654.
117. Muhlhausler BS, McMillen IC, Rouzaud G, et al. Appetite regulatory neuropeptides are expressed in the sheep hypothalamus before birth. J Neuroendocrinol 2004; 16: 502-507.
118. Muhlhausler BS, Adam CL, Marracco, BM, et al. Impact of glucose infusion on the structural and functional characteristics of adipose tissue and on hypothalamic gene expression for appetite regulatory neuropeptides in the sheep fetus during late gestation. J Physiol 2005; 565: 185-195.
119. Das UN. A perinatal strategy for preventing adult disease: The role of long-chain polyunsaturated &tty acids. Kluwer Academic Publishers, Boston, 2002.
120. Barker DJ, Hales CN, Fall CH et al. Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36:62-67.
121. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ 1999; 319:245-249.
122. Axen KV, Li X, Fung K, Sclafani A. The VMH-dietary obese rat: a new model of non-insulin-dependent diabetes mellitus. Am J Physiol 1994; 266(3 Pt2): R921-R928.
123. Keno Y, Tokunaga K, Fujioka S, et al. Marked reduction of pancreatic insulin content in male ventromedial hypothalamic-lesioned spontaneously non-insulin-dependent diabetic (Goto-Kakizaki) rats. Metabolism 1994; 43:32-37.
124. Dube MG, Kalra PS, Crowley WR, Kalra SP. Evidence of a physiological role for neuropeptide Y in ventromedial hypothalamic lesion-induced hyperphagia. Brain Res 1995; 690: 275-278.
125. Funahashi T, Shimomura I, Hiraoka H, et al. Enhanced expression of rat obese (ob) gene in adipose tissues of ventromedial hypothalamus (VMH)-lesioned rats. Biochem Biophys Res Commun 1995; 211: 469-475.
126. Williams G, Gill JS, Lee YC, Cordoso HM, Okpere BE, Bloom SR. Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozotocin-induced diabetic rats. Diabetes 1989; 38: 321-327.
127. Ohtani N, Ohta M, Sugano T. Microdialysis study of modification of hypothalamic neurotransmitters in streptozotocin-diabetic rats. J Neurochem 1997; 69:1622-1628.
128. Takahashi A, Ishimaru H, Ikarashi Y, Maruyama Y. Aspects of hypothalamic neuronal systems in VMH lesion-induced obese rats. J Auton Nerv Syst 1994; 48: 213-219.
129. Barber M, Kasturi BS, Austin ME, et al. Diabetes-induced neuroendocrine changes in rats: role of brain monoamines, insulin and leptin. Brain Res 2003; 964:128-135.
130. Katafuchi T, Okada E, Take S, Hori T. The biphasic changes in splenic natural killer cell activity following ventromedial hypothalamic lesions in rats. Brain Res 1994; 652: 164-168.
131. Horin T, Katafuchi T, Take S, Shimizu N. Neuroimmunomodulatory actions of hypothalamic interferon-alpha. Neuroimmunomodulation 1998; 5: 172-177.
132. Tanebe K, Nishijo H, Muraguchi A, Ono T. Effects of chronic stress on hypothalamic interleukin-1beta, interleukin-2, and gonadotrophin-releasing hormone gene expression in overiectomized rats. J Neuroendocrinol 2000; 12: 13-21.
133. Katafuchi T, Motomura K, Baba S, Ota K, Hori T. Differential effects of tumor necrosis factor-alpha and -beta on rat ventromedial hypothalamic neurons in vitro. Am J Physiol 1997; 272 (6 Pt 2): R1966-R1971.
134. Nishio T, Toyoda Y, Hiramatsu M, Chiba T, Miwa I. Decline in glucokinase activity in the arcuate nucleus of streptozotocin-induced diabetic rats. Biol Pharm Bull 2006; 29:216-219.
135. Yoshida S, Yamashita S, Tokunaga K, et al. Visceral fat accumulation and vascular complications associated with VMH lesioning of spontaneously non-insulin-dependent diabetic GK rat. Int J Obes Relat Metab Disord 1996; 20:909-916.
136. A receptors to postsynaptic domains by insulin. Nature 1997; 388: 686-690.
137. Bruning JC, Gautam D, Burks DJ, et al. Role of brain insulin receptor in control of body weight and reproduction. Science 2000; 289: 2122-2125.
138. Hill JM, Desniak MA, Pert CB, Roth J. Autoradiographic localization of insulin receptors in rat brain: prominence in olfactory and limbic areas. Neuroscience 1986; 17: 1127-1138.
139. Rothwell NJ, Saville ME, Stock MJ. Role of insulin in the thermogenic responses to refeeding in 3-day-fatsed rats. Am J Physiol 1983; 245: E160-E165.
140. Menendez JA, Atrens DM. Insulin and the paraventricular hypothalamus: modulation of energy balance. Brain Res 1991; 555: 193-201.
141. McGowan MK, Andrews KM, Grossman SP. Chronic intrahypothalamic infusions of insulin or insulin antibodies alter body weight and food intake in the rat. Physiol Behav 1992; 51: 753-766.
142. Obici S, Feng Z, Karkanias G, Baskin DG, Rossetti L. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002; 5: 566-572.
143. Torsoni MA, Carvalheira JB, Pereira-Da-Silva M, de Carvalho-Filho MA, Saad MJ, Velloso LA. Molecular and functional resistance to insulin in hypothalamus of rats exposed to cold. Am J Physiol Endocrinol Metab 2003; 285: E216-E223.
144. Kubota N, Terauchi Y, Tobe K, et al. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest 2004; 114: 917-927.
145. Lin X, Taguchi A, Park S, et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest 2004; 114: 908-916.
146. Burks DJ, de Mora JF, Schubert M, et al. IRS-2 pathways integrate female reproduction and energy homeostasis. Nature 2000; 407: 377-382.
147. Schwartz MW, Sipols AJ, Marks JL, et al. Inhibition of hypothalamic neuropeptide Y gene expression by insulin. Endocrinology 1992; 130: 3608-3616.
148. Sipols AJ, Baskin DG, Schwartz MW. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression. Diabetes 1995; 44: 147-151.
149. Benoit SC, Air EL, Coolen LM, et al. The catabolic action of insulin in the brain is mediated by melanocortins. J Neurosci 2002; 22: 9048-9052.
150. Air EL, Benoit SC, Clegg DJ, Seeley RJ, Woods SC. Insulin and leptin combine additively to reduce food intake and body weight in rats. Endocrinology 2002; 143: 2449-2452.
151. Schwartz MW. Central nervous system control of food intake. Nature 2000; 404: 661-671.
152. Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford ML. Insulin activates ATP-sensitive K+ channels in hypothalamic neurons of lean, but not obese rats. Nat Neurosci 2000; 3: 757-758.
153. Wang R, Liu X, Hentges ST, et al. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 2004; 53: 1959-1965.
154. Harvey J, Ashford ML. Leptin in the CNS: much more than a satiety signal. Neuropharmacology 2003; 44: 845-854.
155. Mirshamsi S, Laidlaw HA, Ning K, et al. Leptin and insulin stimulation of signalling pathways in arcuate nucleus neurones: P13K dependent actin reorganization and KATP channel activation. BMC Neurosci 2004; 5: 54.
156. Ikeda H, West DB, Pustek JJ, et al. Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats. Appetite 1986; 7: 381-386.
157. Schwartz MW, Marks J, Sipols AJ, et al. Central insulin administration reduces neuropeptide Y mRNA expression in the arcuate nucleus of food-deprived lean (Fa/Fa) but not obese (fa/fa) Zucker rats. Endocrinology 1991; 128: 2645-2647.
158. Lynch RM, Tompkins LS, Brooks HL, Dunn-Meynell AA, Levin BE. Localization of glucokinase gene expression in the rat brain. Diabetes 2000; 49: 693-700.
159. Dunn-Meynell AA, Routh VH, Kang L, Gaspers L, Levin BE. Glucokinase is the likely mediator of glucosensing in both glucose-excited and glucose-inhibited central neurons. Diabetes 2002; 51: 2056-2065.
160. Kang L, Routh VH, Kuzhikandathil EV, Gaspers LD, Levin BE. Physiological and molecular characteristics of rat hypothalamic ventromedial nucleus glucosensing neurons. Diabetes 2004; 53: 549-559.
161. Sahu A, Dube MG, Phelps CP, Sninsky CA, Kalra PS, Kalra SP. Insulin and insulin-like growth factor II suppress neuropeptide Y release from the nerve terminals in the paraventricular nucleus: a putative hypothalamic site for energy homeostasis. Endocrinology 1995; 136: 5718-5724.
162. Chan JC, Cheung JC, Stehouwer CD, et al. The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome - an analysis by structural equation modelling. Int J Obes Relat Metab Disord 2002; 26: 994-1008.
163. Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res 2004; 12:180-186.
164. Nesto R. C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med 2004; 21: 810-817.
165. Johnson FK, Johnson RA, Durante, W, Jackson KE, Stevenson BK, Peyton KJ. Metabolic syndrome increases endogenous carbon monoxide production to promote hypertension and endothelial dysfunction in obese Zucker rats. Am Physiol Regul Integr Comp Physiol 2006; 290: R601-R608.
166. Cook S, Hugli O, Egli M, et al. Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med Wkly 2003; 133: 360-363.
167. Cardillo C, Nambi SS, Kilcoyne CM, et al. Insulin stimulates both endothelin and nitric oxide activity in the human forearm. Circulation 1999; 100:820-825.
168. Barker DJP, Ed. Fetal and infant origins of adult disease. London; BMJ Publishing, 1992.
169. Robinson R. The fetal origins of adult disease. BMJ 2001; 322: 375-376.
170. Das UN. Essential fatty acids: Biochemistry, physiology, and pathology. Biotechnol J 2006; 1: 420-439.
171. Das UN. Biological significance of essential fatty acids. J Assoc Physicians India 2006; 54: 309-319.
172. Matsuzaka T, Shimano H, Yahagi N, et. al. Dual regulation of mouse Delta(5)- and Delta(6)-desaturase gene expression by SREBP-1 and PPARalpha. J Lipid Res 2002; 43: 107-114.
173. Auestad N, Scott DT, Janowsky JS, et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 2003; 112(3 Pt 1): e177-83.
174. Fewtrell MS, Morley R, Abbott RA, et al. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics 2002; 110(1 Pt 1): 73-82.
175. SanGiovanni JP, Parra-Cabrera S, Colditz GA, Berkey CS, Dwyer JT. Metaanalysis of dietary essential fatty acids and long-chain polyunsaturated fatty acids as they relate to visual resolution acuity in healthy preterm infants. Pediatrics 2000; 105: 1292-1298.
176. O'Connor DL, Hall F, Adamkin D, et al. Ross Preterm Lipid Study. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics 2001; 108: 359-371.
177. Boehm G, Borte M, Bohles HJ, Muller H, Kohn G, Moro G. Docosahexaenoic and arachidonic acid content of serum and red blood cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long-chain polyunsaturated fatty acids. Eur J Pediatr 1996; 155: 410-416.
178. Fewtrell MS, Abbott RA, Kennedy K, et al. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004; 144: 471-479.
179. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998; 352: 688-691.
180. Salem Jr N, Wegher B, Mena P, Uany R. Arachidonic and docosahexaenoic acids are biosynthesized from their 18-carbon precursors in human infants. Proc Natl Acad Sci USA 1996; 93: 49-54.
181. Farquharson J, Jamieson EC, Abbasi KA, Patrick WJA, Logan RW, Cockburn F. Effect of diet on the fatty acid composition of the major
182. Yu N, Martin J-L, Stella N, Magistretti PJ. Arachidonic acid stimulates glucose uptake in cerebral cortical astrocytes. Proc Natl Acad Sci USA 1993; 90: 4042-4046.
183. Ragozzino ME, Unick KE, Gold PE. Hippocampal acetylcholine release during memory testing in rats: Augmentation by glucose. Proc Natl Acad Sci USA 1996; 93: 4693-4698.
184. Das UN. Alcohol consumption and risk of dementia. Lancet 2002; 360: 490.
185. Minami M, Kimura S, Endo T, et al. Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997; 58: 1123-1129.
186. Hersi AI, Kitaichi K, Srivastava LK, Gaudreau P, Quirion R. Dopamine D-5 receptor modulates hippocampal acetylcholine release. Brain Res Mol Brain Res 2000; 76: 336-340.
187. Wang G-J, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet 2001; 357: 354-357.
188. Abott MA, Wells DG, Fallon JR. The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J Neurosci 1999; 19: 7300-7308.
189. Venters HD, Dantzer R, Kelley KW, et al. A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci 2000; 23: 175-180.
190. Venters HD, Tang Q, Liu Q, et al. A new mechanism of neurodegeneration: proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 1999; 96: 9879-9884.
191. Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M. Polyunsaturated fatty acids are potent neuroprotectors. EMBO J 2000; 19: 1784-1793.
192. Wang X, Zhao X, Mao ZY, Wang XM, Liu ZL. Neuroprotective effect of docosahexaenoic acid on glutamate-induced cytotoxicity in rat hippocampal cultures. Neuroreport 2003; 14: 2457-2461.
193. Cao D, Xue R, Xu J, Liu Z. Effects of docosahexaenoic acid on the survival and neurite outgrowth of rat cortical neurons in primary cultures. J Nutr Biochem 2005; 16: 538-546.
194. Hogyes E, Nyakas C, Kiliaan A, Farkas T, Penke B, Luiten PG. Neuroprotectivo effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience 2003, 119: 999-1012.
195. Lonergan PE, Martin DS, Horrobin-DF, Lynch MA. Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation. J Biol Chem 2002; 277: 20804-20811.
196. Das UN, Rao KP. Effect of γ-linolenic acid and prostaglandins E1 on gamma-radiation and chemical-induced genetic damage to the bone marrow cells of mice. Prostaglandins Leukot Essen Fatty Acids 2006; 74:165-173.
197. Kumar SG and Das UN. Effect of Prostaglandins and their precursors on the proliferation of human lymphocytes and their secretion of tumor necrosis factor and various interleukins. Prostaglandins Leukotr Essen Fatty Acids 1994; 50: 331-334.
198. Kumar SG, Das UN, Kumar KV, Tan BKH, Das NP. Effect of n-6 and n-3 fatty acids on the proliferation and secretion of TNF and IL-2 by human lymphocytes in vitro. Nutrition Res 1992; 12: 815-823.
199. Endres S, Ghorbani R, Kelley VE, et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989; 320: 265-271.
200. Kuboki K, Jiang ZY, Takahara N, et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 2000; 101: 676-681.
201. Das UN. Beneficial effect of eicosapentaenoic and docosahexacnoic acids in the management of systemic lupus erythematosus and its relationship to the cytokine network. Prostaglandins Leukot Essen Fatty Acids 1994; 51: 207-213.
202. Satomi N, Sakurai A, Hatanaka K. Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin and macrophages. J Natl Cancer Inst 1985; 74: 1255-1260.
203. Boichot E, Sannomiya P, Escofier N, et al. Endotoxin-induced acute lung injury in rats: Role of insulin. Pulm Pharmacol Ther 1999; 12: 285-290.
204. Guidot DM, Hybertson BM, Kitlowski RP, Repine JE. Inhaled nitric oxide prevents IL-1 induced neutrophil accumulation and associated acute edema in isolated rats lungs. Am J Physiol 1996; 271: L225-L229.
205. Suresh Y, Das UN. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: Effect of ω-3 fatty acids. Nutrition 2003; 19: 213-228.
206. Nilsson L, Sara VR, Norberg A. Inolin-like growth factor 1 stimulates the release of acetylcholine from rat cortical slices. Neurosci Lett 1988; 88: 221-226.
207. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
208. Xu Z, Tong C, Eisenach JC. Acetylcholine stimulates the release of nitric oxide from rat spinal cord. Anesthesiology 1996; 85: 107-111.
209. Borkman M, Stolien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty acid composition of skeletal muscle phospholipids. N Engl J Med 1993; 328: 238-244.
210. 5 desaturases may be a factor predisposing to the development of insulin resistance syndrome. Prostaglandins Leukotr Essen Fatty Acids 2005; 72: 343-350.
211. Ginsberg BH, Jabour J, Spector A.A. Effect of alterations in membrane lipid unsaturation on the properties of the insulin receptor of Ehrlich ascites cells. Biochim Biophys Acta 1982; 690: 157-164.
212. Somova L, Moodley K, Channa, ML, Nadar A. Dose-dependent effect of dietary fish-oil (n-3) polyunsaturated fatty acids on In vivo insulin sensitivity in rat. Methods Find Exp Clin Pharmacol 1999; 21: 275-278.
213. Huang Y-J, Fang VS, Chou Y-C Kwok C-F, Ho L-T. Amelioration of insulin resistance and hypertension in a fructose-fed rat model with fish oil supplementation. Metabolism 1997; 46: 1252-1258.
214. Mori Y, Murakawa Y, Katoh S, et al. Influence of (highly purified eicosapentaenoic acid ethyl ester on insulin resistance in the Otsuka Long-Evans Tokushima fatty rat, a model of spontaneous non-insulin dependent diabetes mellitus. Metabolism 1997; 46: 1458-1464.
215. Nobukata H, Ishikawa T, Obata M, Shibutani Y. Long-term administration of highly purified eicosapenatenoic acid ethyl ester prevents diabetes and abnormalities of blood coagulation in mate WBN/Kob rats. Metabolism 2000; 49: 912-919.
216. Demcakova E, Sebokova E, Ukropec J, Gasperikova D, Klimes I. Delta-6 desaturase activity and gene expression, tissue fatty acid profile and glucose turnover rate in hereditary hypertriglyceridemic rats. Endocrinol Regul 2001; 35: 179-186.
217. Gasperikova D, Demcakova E, Ukropec J, Klimes I, Sebokova E. Insulin resistance in the hereditary hypertriglyceridemic rat is associated with an impairment of delta-6 desaturase expression in liver. Ann N Y Acad Sci 2002; 967: 446-453.
218. Simoncikova P, Wein S, Gasperikova D, et al. Comparison of the extrapancreatic action of gamma-linotenic acid and n-3 PUFAs in the high fat diet-induced insulin resistance. Endocr Regul 2002; 36: 143-149.
219. Hajnal A, Pothos EN, Lenard L, Hoebel BG. Effects of feeding and insulin on extracellular acetylcholine in the amygdala of freely moving rats. Brain Res 1998; 785: 41-48.
220. Futerman AH, Banker GA. The economics of neurite outgrowth: the addition of new membrane to growing axons. Trends Neurosci 1996; 19: 144-149.
221. Negre-Aminou P, Nemenoff RA, Wood MR, de la Houssaye BA, Pfenninger KH. Characterization of phospholipase A2 activity enriched in the nerve growth cone. J Neurochem 1996; 67: 2599-2608.
222. Hornfelt M, Ekstrom PA, Edstrom A. Involvement of axonal phospholipase A2 activity in The outgrowth of adult mouse sensory axons in vitro. Neuroscience 1999; 91: 1539-1547.
223. Kelly RB. Deconstructing membrane traffic. Trends Cell Biol 1999; 9: M29-M33.
224. Darios F, Davletov B. Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006; 440: 813-817.
225. Rickman C, Davletov B. Arachidonic acid allows SNARE complex formation in the presence of Muncl8. Chem Biol 2005; 12: 545-553.
226. van der Wees J, Schilthuis JG, Koster CH, et al. Inhibition of retinoic acid receptor-mediated signalling alters positional identity in the developing hindbrain. Development 1998; 125: 545-556.
227. Mata de Urquiza A, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, Perlmann T. Docosahoutenoic acid, a ligand for the retithoid X receptor in mouse brain. Science 2000; 290: 2140-2144.
228. Fan Y-Y, Spencer TE, Wang N, Moyer MP, Chapkin RS. Chemopreventive n-3 fatty acids activate RXRα in colonocytes. Carcinogenesis 2003; 24: 1541-1548.
229. Lengqvist J, Mata de Urquiza, Bergman A-C, et al. Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor α ligand-binding domain. Mel Cell Proteomics 2004; 3: 692-703.
230. DeWille JW, Farmer SJ. Postnatal dietary fat influences mRNAS involved in myelinstion, Dev Neurosci 1992; 14:61-68.
231. Kitajka K, Sinclair AJ, Weisinger RS, et al. Effects of dietary omega-3 polyunsatumted fatty acids on brain gene expression. Proc Natl Acad Sci USA 2004; 101: 10931-10936.
232. Kitajka K, Puskas LG, Zvara A, et al. The role of n-3 polyunsaturated fatty acids in brain: Modulation of rat brain gene expression by dietary n-3 fatty acids. Proc Natl Acad Sci USA 2002; 99: 2619-2624.
233. Barcelo-Coblijn G, Hogyes E, Kitajka LG, et al. Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci USA 2003; 100: 11321-11326.
234. Puskas LG, Kitajka. K, Nyakas C, Barcelo-Coblijn G, Farkas T. Short-term administration of omega 3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci USA 2003; 100: 1580-1585.
235. Galvin JE, Schuck TM, Lee VM, Trojanowski JQ. Differential expression and distribution of alpha-, beta-, and gamma-synuclein in the developing human substantia nigra. Exp Neurol 2001; 168: 347-355.
236. Berger A, Mutch DM, German JB, Roberts MA. Dietary effects of arachidonate-rich fungal oil and fish oil on murine hepatic and hippocampal gene expression. Lipids Health Dis 2002; 1:2.
237. Stellwagen D, Malenka RC. Synaptic scaling mediated by glial TNF-α. Nature 2006; 440: 1054-1059.
238. Beattie EC, Stellwagen D, Morishita W, et al. Control of synaptic strength by glial TNFα. Science 2002; 295: 2282-2285.
239. Colombani J, Bianchini L, Layalle S, et al. Antagonistic actions of ecdysone and insulins determine final size in Drosophila. Science 2005; 310: 667-670.
240. Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005; 310: 314-317.
241. Chenn A, Zhang YA, Chang BT, McConnell SK. Intrinsic polarity of mammalian neuroepithelial cells. Mol Cell Neurosci 1998; 11: 183-193.
242. Lien W-H, Klezovitch O, Fernandez TE, Delrow J, Vasioukhin V. αE-catenin controls cerebral cortical size by regulwing the hedgehog signaling pathway. Science 2006; 311: 1609-1611.
243. 2 promotes colon cancer growth through a G.-axin-β-catenin signaling axis. Science 2005; 310: 1504-1510.
244. Cai J, Jiang WG, Mansell RE. Inhibition of the expression of VE-cadherin/ catenin complex by gamma linolenic acid in human vascular endothelial cells, and its impact on angiogenesis. Biochem Biophys Res Commun 1999; 258:113-118.
245. Jiang WG, Hiscox S, Horrobin DF, Hallett MB, Mansel RE, Puntis MC. Expression of catenins; in human cancer cells and its regulation by n-6 polyunsaturated fatty acids. Anticancer Res 1995; 15:2569-2573.
246. Carayol N, Vachier I, Campbell A, et al. Regulation of E-cadherin expression by dexamethasone and tumour necrosis factor-alpha in nasal epithelium. Eur Respir J 2002; 20:1430-1436.
247. Lam TKT, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005; 309:943-947.
248. Woods SC, McKay LD. Intraventricular alloxan eliminates feeding elicited by 2-deoxyglucose. Science 1978; 202:1209-1211.
249. Woods SC, Lotter EC, McKay LD, Porte D Jr. Chronic intracere-broventricular infusion of insulin reduces food intake and body weight of baboons. Nature 1979; 292:503-505.
250. Rossetti L, Shulman GI, Zawalich W, Defronzo RA. Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatecomized rats. J Clin Invest 1987; 80:1037-1044.
251. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rossetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 1998; 102:744-753.
252. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998; 17: 1371-1384.
253. Itoh K, Krupnik VE, Sokol SY. Axis determination in Xenopus involves biochemical interactions of axin, glycogen synthase kinase 3 aRO beta-catenin. Curr Biol 1998, 8: 591-594.
254. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997; 16: 3797-3804.
255. Fagotto F, Gluck U, Gumbiner BM. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr Biol 1998; 8: 181-190.
256. Yost C, Farr III GH, Pierce SB, Ferke DM, Chen MM, Kimerlman D. GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell 1998; 93: 1031-1041.
257. Brannon M, Gomperts M, Sumoy L, Moon RT, Kimelman D. A beta-catenin/ XTcf-3 complex binds to the siamois promoter to regulate dorsal axis specification in Xenopus. Genes Dev 1997; 11: 2359-2370.
258. Carron C, Pascal A, Djiane A, Boucaut J-C, Shi D-L, Umbhauer M. Frizzled receptor dimerization is sufficient to activate the Wnt/β-catenin pathway. J Cell Sci 2003; 116: 2541-2550.
259. Haq S, Michael A, Andreucci M, et al. Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth. Proc Natl Acad Sci USA 2003; 100: 4610-4615.
260. Mikels AJ, Nusse R. Purified Wnt5a protein activates or inhibits β-catenin-TCF signaling depending on receptor context. PLoS Biol 2006; 4: e115.
261. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512.
262. He TC, Chan TA, Vogelstein B, Kinzler KW. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999; 99: 335-345.
263. Shtutman M, Zhurinsky J, Simcha I, et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-5527.
264. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-426.
265. Howe LR, Subbaramaiah K, Chung WJ, Dannenberg AJ, Brown AMC. Transcriptional activation of cyclooxygemase-2 in Wnt-1-transformed mouse mammary epithetial cells. Cancer Res 1999; 59: 1572-1577.
266. Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AMC. PEA3 is up-regutatted in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 2001; 276: 20108-20115.
267. Haertel-Wiesmann M, Liang Y, Fantl WJ, Williams LT. Regulation of cyclooxygenase-2 and periostin by Wnt-3 in mouse mammary epithelial cells. J Biol Chem 2000; 275: 32046-32051.
268. Xu HE, Lambert MH, Montana VG, et al. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 1999; 3: 397-403.
269. Nakamura T, Sano M, Songyang Z, Schneider MD. A Wnt- and beta-catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci USA 2003; 100: 5834-5839.
270. Salic A, Lee E, Mayer L, Kirschner MW. Control of beta-catenin stability: reconsitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell 2000; 5: 523-532.
271. Hardt SE, Sadoshima J. Glycogen synthase kinase-3veta: a novel regulator of cardiac hypertrophy and development. Circ Res 2002; 90: 1055-1063.
272. Phili-Couderc P, Pathak A, Smith F, Dambrin C, Harmancey R, Buys S, Galinier M, Massabuau P, Roncalli J, Senard J-M, Rouet P. Uncomplicated human obesity is associated with a specific cardiac transcriptome: involvement of the Wnt pathway. FASEB J 2004; 18:1539-1540.
273. Innis SM, de La Presa Owens S. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr 2001; 131: 118-122.
274. de La Presa Owens S, Innis SM. Diverse, region-specific effects of addition of arachidonic and docosahexaenoic acids to formula with low or adequate linoleic and alpha-linolenic acids on piglet brain monoaminergic neurotransmitters. Pediatr Res 2000; 48: 125-130.
275. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 2003; 111: 39-44.
276. Whalley LJ, Fox HC, Wahle KW, Staff JM, Deary IJ. Cognitive aging, childhood intelligence, and the use of food supplements: possible involvement of n-3 fatty acids. Am J Clin Nutr 2004; 80: 1650-1657.
277. Gustafsson PA, Duchen K, Birberg U, Karlsson T. Breastfeeding, very long polyunsaturated fatty acids (PUFA) and IQ at 6 1/2 years of age. Acta Paediatr 2004; 93: 1280-1287.
278. Auestad N, Scott DT, Janowsky JS, et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics 2003; 112(3 Pt 1): e177-183.
279. Willatts P, Forsyth JS, DiModugno MK, Varma S, Colvin M. Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age. Lancet 1998; 352: 688-691.
280. de La Presa Owens S, Innis SM. Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. J Nutr 1999; 129: 2088-2093.
281. Kuperstein F, Yakubov E, Dinerman. P, Gil S, Eylam R, Salem N Jr, Yavin E. Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n-3 fatty acid dietary deficiency. J Neurochem 2005; 95: 1550-1562.
282. Acar N, Chardigny JM, Berdeaux O, Alamnza S, Sebedio JL. Modification of the monoaminergic neurotransmitters in frontal cortex and hippocampus by dietary trans alpha-linolenic acid in piglets. Neurosci Lett 2002; 331:198-202.
283. Delion S, Chalon S, Guilloteau D, Besnard JC, Durand G. Alpha-Linolenic acid dietary deficiency alters age-related changes of dopaminergic and serotoninergic neurotransmission in the rat frontal cortex. J Neurochem 1996; 66: 1582-1591.
284. Cunha RA, Ribeiro JA. Facilitation of GABA release by arachidonic acid in rat hippocampal synaptosomes. Eur J Neurosci 1999; 11: 2171-2174.
285. Cheramy A, Artaud F, Godeheu G, L'hirondel M, Glowinski J. Stimulatory effect of arachidonic acid on the release of GABA in matrix-enriched areas from the rat striatum. Brain Res 1996; 742: 185-194.
286. Nabekura J, Noguchi K, Witt MR, Neilsen M, Akaike N. Functional modulation of human recombinant gamma-aminobutyric acid type A receptor by docosahexaenoic acid. J Biol Chem 1998; 273: 11056-11061.
287. Hamano H, Nabekura J, Nishikawa M, Ogawa T. Docosahexaenoic acid reduces GABA response in substantia nigra neuron of rat. J Neurophysiol 1996; 75: 1264-1270.
288. Almeida T, Cunha RA, Ribeiro JA. Facilitation by arachidonic acid of acetylcholine release from the rat hippocampus. Brain Res 1999; 826: 104-111.
289. Blanchet F, Gauchy C, Perez S, Glowinski J, Kemel ML. Role of arachidonic acid in the regulation of the NMDA-evoked release of acetylcholine in striatal compartments. Synapse 1999; 31: 140-150.
290. Aid S, Vancassel S, Linard A, Lavialle M, Guesnet P. Dietary docosahexaenoic acid [22: 6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 2005; 135: 1008-1013.
291. Minami M, Kimura S, Endo T, et al. Dietary docosahexaenoic acid increases. cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats. Pharmacol Biochem Behav 1997; 58: 1123-1129.
292. Zhang L, Reith ME. Regulation of the functional activity of the human dopamine transporter by the arachidonic acid pathway. Eur Pharmacol 1996; 315: 345-354.
293. L'hirondel M, Cheramy A, Godeheu G, Glowinski J. Effects of arachidonic acid on dopamine synthesis, spontaneous release, and uptake in striatal synaptosomes from the rat. J Neurochem 1995; 64: 1406-1409.
294. Piomelli D, Pilon C, Giros B, Sokoloff P, Martres MP, Schwartz JC. Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 1991; 353: 164-167.
295. Rodriguez Y, Christophe AB. Long-chain omega6 polyunsaturated fatty acids in erythrocyte phospholipids are associated with insulin resistance in non-obese type 2 diabetics. Clin Chim Acta, 2005; 354: 195-199.
296. Enriquez YR, Giri M, Rottiers R, Christophe A. Fatty acid composition of erythrocyte phospholipids is related to insulin levels, secretion and resistance in obese type 2 diabetics on Metformin. Clin Chim Acta 2004; 346: 145-152.
297. Borkman M, Storlien LH, Pan DA, Jenkins AB, Chisholm DJ, Campbell LV. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med 1993; 328: 238-244.
298. Das UN, Vijay Kumar K and Krishna Mohan I. Lipid peroxides and essential fatty acids in patients with diabetes mellitus and diabetic nephropathy. J Nutr Med 1994; 4: 149-155.
299. Warensjo E, Ohrvall, M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc Dis 2006; 16: 128-136.
300. Ozanne SE, Martensz ND, Petry CJ, Loizou CL, Hales CN. Maternal low protein diet in rats programmes fatty acid desaturase activities in the offspring. Diabetologia 1998; 41: 1337-1342.
301. Bhattacharjee AK, Chang L, Lee HJ, Bazinet RP, Seemann R, Rapoport SI. D2 but not D1 dopamine receptor stimulation augments brain signaling involving arachidonic acid in unanesthetized rats. Psychopharmacology (Berl) 2005; 180: 735-742.
302. Campfield IA, Smith FJ, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269: 546-549.
303. Pelleymounter M, Cullen M, Baker M, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269: 540-143.
304. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252.
305. Chehab FF, Mounzih K, Lu R, Lim ME. Early onset of reproductive function in normal female mice treated with leptin. Science 1997; 275: 88-90.
306. Heiman MI, Ahima RS, Craft LS, Schoner B, Stephens TW, Flier JS. Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 1997; 138: 3859-3863.
307. Bereiter DA, Jeanrenaud B. Altered neuroanatomical organization in the central nervous system of the genetically obese (ob/ob) mouse. Brain Res 1979; 165: 249-260.
308. Bereiter DA, Jeanrenaud B. Altered dendritic orientation of hypothalamic neurons from genetically obese (ob/ob) mice. Brain Res 1980; 202:201-212.
309. Sena A, Sarliene LI, Rebel G. Brain myelin of genetically obese mice. J Neurol Sci 1985; 68: 233-243.
310. Ahima RS, Prabakaran D, Flier JS. Postnatal leptin surge and regulation of circadian rhythm of leptin by feeding. J Clin Invest 1998; 101: 1020-1027.
311. Bouret SG, Draper SJ, Simerly RB. Trophic action of leptin on hypothalamic neurons that regulate feeding. Science 2004; 304: 108-110.
312. Cowley M, Smart JL, Rubinstein M, Cerdan MG, Diano S, Horvath TL, Cone RD, Low MJ. Leptin activates anorexiganic POMC-neurons through a neural network in the arcuate nucleus. Nature 2001; 411: 480-484.
313. Schwartz MW, Seeley RJ, Woods SC, Weigle DS, Campfield LA, Burn P, Baskin DG. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus. Diabetes 1997; 46: 2119-2123.
314. Stephens TW, Basinski M, Bristow PK, et al. The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 1995; 377: 530-53.
315. Pinto S, Roseberry AG, Liu H, Diano S, Shanabrough M, Cai X, Friedman JM, Horvath TL. Rapid rewiring of arcuate nucleus feeding circuits by leptin. Science 2004; 304: 110-115.
316. Elmquist JK, Flier JS. The fat-brain axis enters a new dimension. Science 2004; 304: 63-64.
317. Phipps K, Barker DJ, Hales CN, et al. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36: 225-228.
318. Barker DJ, Hales CN, Fall CH, et al. Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-67.
319. Lucas A, Fewtrell MS, Cole TJ. Fetal origins of adult disease-the hypothesis revisited. BMJ 1999; 319: 245-249.
320. Das UN. Essential fatty acids: biology and their clinical implications. Asia Pacific J Pharmacol 1991; 16: 317-330.
321. Das UN. Essential fatty acids in health and disease. J Assoc Physicians India 1999; 447: 906-911.
322. Mercuri O, de Tomas E, Itarte H. Prenatal protein depletion and δ9, δ6, and δ5 desaturases in the rat. Lipids 1979; 14: 822-825.
323. Trottier G, Koski KG, Brun T, Toufexis DJ, Richard D, Walker CD. Increased fat intake during lactation modifies hypothalamic-pituitary-adrenal responsiveness in developing rat pups: a possible role for leptin. Endocrinology 1998; 139: 3704-3711.
324. Frederich RC, Hamann A, Anderson S, Lollmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nature Med 1995; 1: 1311-1314.
325. Cha MC, Jones PJH. Dietary fat type and energy restriction interactively influence plasma leptin concentrations in rats. J Lipid Res 1998; 39: 1655-1660.
326. Korotkova M, Gabrielsson B, Hanson LA, Strandvik B. Maternal essential fatty acid deficiency depresses serum leptin levels in suckling rat pups. J Lipid Res 2001; 42: 359-365.
327. Korotkova M, Gabrielsson B, Hanson LA, Strandvik B. Maternal dietary intake of essential fatty acids affects adipose tissue growth and leptin mRNA expression in suckling rat pups. Pediatr Res 2002; 52: 78-84.
328. Dhalgren J, Nilsson C, Jennische E, et al. Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol 2001; 281: E326-E334.
329. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, et al. Serum concentrations of TNF-α and soluble TNF-α receptors in obesity. Int J Obes 2000; 24: 1392-1395.
330. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukins-6: depot differences and regulation by glucocorticoid. J Clin Endocrinol Metab 1998; 83: 847-850.
331. Rask E, Walker BR, Soderberg S, et al. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased 11β-hydroxysteroid dehydrogenase type 1 activity. J Clin Endocrinol Metab 2002; 87: 3330-3336.
332. Das UN. Can perinatal-supplementation of long-chain polyunsaturated fatty acids prevent hypertension in adult life? Hypertension 2001; 38: e6-e8.
333. Das UN. Can perinatal supplementation of long-chain polyunsaturated fatty acids prevent diabetes mellitus? Eur J Clin Nutr 2003; 57: 218-226.
334. Carlson SE, Rhodes PG, Ferguson MG. DHA status of preterm infants at birth and following feeding with human milk or formula. Am J Clin Nutr 1985; 44: 798-804.
335. Cunname SC, Francescutti V, Brenna T, Crawford MA. Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoic accumulation than formula-fed infants not consuming dietary docosahexaenoate. Lipids 2000; 35: 105-111.
336. Boehm G, Borte M, Bohles BJ, Muller H, Kohn, Moro G. Docosahexaenoic and arachidonic acid content of serum and red blood cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long-chain polyunsaturated fatty acids. Eur J Pediat 1996; 155: 410-416.
337. Mattson MP and Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 2001; 107: 247-254.
338. Weisinger HS, Armitage JA, Sinclair AJ, Vingrys AJ, Burns PL, Weisinger RS. Perinatal omega-3 deficiency affects blood pressure later in life. Nature Med 2001; 7: 258-259.
339. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-aceylethanolamines in piglets. Proc Natl Acad Sci USA 2001; 98: 6402-6406.
340. Di Marzo V, Goapraju SG, Wang L, et al. Leptin-regulated endocannabinoids are involyed in maintaining food intake. Nature 2001; 410: 822-825.
341. Reseland JE, Haugen F, Hollung K, et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001; 42: 743-750.
342. Das UN. Nutritional factors in the pathobiology of human essential hypertension. Nutrition 2001; 17: 337-346.
343. Das UN. Oestrogen, statins and polyunsaturated fatty acids: Similarity in their actions and benefits-Is there a common link? Nutrition 2002; 18: 178-188.
344. Wijendran V, Bendel RB, Couch SC, Philipson EH, Cheruku S, Lammi-Keefe CJ. Fetal erythrocyte phospholipid polyunsaturated fatty acids are altered in pregnancy complicated with gestational diabetes mellitus. Lipids 2000; 35: 927-931.
345. Bisschop, PH, de Metz J, Ackermans MT, et al. Dietary fat content alters insulin-mediated glucose metabolism in healthy men. Am J Clin Nutr 2001; 73: 554-559.
346. Vessby B, Uusitupa MI Hermansen K, Riccardi G, Rivellese AA, Tapsell LC, Nalsen C, Berglund L, Louheranta A, Rasmussen BM, Calvert GD, Maffetone A, Pedersen E, Gugtafsson I-B, Storlien LH. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 2001; 44: 312-319.
347. Hu FB, van Dam RM, Liu S. Diet and risk of type II diabetes: the role of types of fat and carbohydrate. Diabetologia 2001; 44: 805-817.
348. Salmeron J, Hu FB, Manson JE, et al. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001; 73: 1019-1026.
349. Prado MD, Villalpando S, Elizondo A, Rodriguez M, Demmelmair H, Koletzko B. Contribution of dietary and newly formed arachidonic acid to human milk lipids in women eating a low-fat diet. Am J Clin Nutr 2001; 74: 242-247.
350. Todoric J, Loffler M, Huber J, et al. Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids. Diabetologia. 2006; 49: 2109-2119.
351. White PJ, Marette A. Is omega-3 key unlocking inflammation in obesity? Diabetologia 2006; 49: 1999-2001.
352. Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L. Central administration of oleci acid inhibits glucose production and food intake. Diabetes 2002; 51: 271-275.
353. Spanswick D, Smith MA, Groppi VE, Logan SD, Ashford MLJ. Leptin inhibits hypothalamic neurons by activation of ATP-sensitive potassium channels. Nature 1997; 390: 521-525.
354. Harvey J, McKay NG, Walker KS, Van der Kay J, Downes CP, Ashford MLJ. Essential role of phosphoinositide 3-kinase in leptin-induced kATP channel activation in the rat CRI-GI insulinoma cell line. J Biol Chem 2000; 275: 4660-4669.
355. Spanswick D, Smith MA, Mirshamsi S, Routh VH, Ashford MLJ. Insulin activates ATP-sensitive K+ channels in hypothalamic neuronsof lean, but not obse rats. Nat Neurosci 2000; 3: 757-762.
356. Loftus TM, Jaworsky DE, Frehywot GL, et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 2000; 288: 2379-2381.
357. McGarry GD, Mannaert GP, Foster DW. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977; 60: 265-270.
358. Ruderman NB, Saha AK, Vavvas D, Witters LA. Malonyl-CoA fuel sensing and insulin resistance. Am J Physiol 1999; 276: E1-E18.
359. Lam TKT, Gutierrez-Juarez R, Pocai A, Rossetti L. Regulation of blood glucose by hypothalamic pyruvate metabolism. Science 2005; 309: 943-947.
360. Das UN. Pyruvate is an endogenous anti-inflammatory and anti-oxidant molecule. Med Sci Monit 2006; 12: RA79-RA84.
361. Ainscow EK, Mirshamsi S, Tang T, Ashford ML, Rutter GA. Dynamic imaging of free cytosolic ATP concentration during fuel sensing by rat
362. + channel-indepondent mechanism is involved in glucose-excited neurons of mouse arcuate nucleus. Diabetes 2004; 53: 2767-2775.
363. Leloup C, Magian C, Benani A, et al. Mitochondrial reactive oxygen species are required for hypothalamic glucose sensing. Diabetes 2006; 55: 2084-2090.
364. + (KATP) channels by H2O2 underlies glutamate-dependent inhibition, of striatal dopamine release: Proc Natl Acad Sci USA 2003; 100: 11729-11734.
365. Annunziato L, Pannaccione A, Cataldi M, et al. Modulation of ion channels by reactive oxygen species and nitrogen species: a pathological role in brain aging? Neurobiol Aging 2002; 23: 819-834.
366. Aarts MM, Tymianski M. TRPMs and neuronal cell death. Pflugers Arch 2005; 451: 243-249.
367. Dukes ID, McIntyre MS, Mertz RJ, et al. Dependence on NADH produced during glycolysis for bete-cell glucose signaling. J Biol Chem 1994; 269: 10979-10982.
368. Eto K, Tsubamoto Y, Terauchi Y, et al. Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. Science 1999; 283: 981-985.
369. Peters JH, Simasko SM, Ritter RG. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin. Physiol Behav 2006; 89: 477-485.
370. Ueno N, Dube MG, Inui A, Kalra PS, Kalra SP. Leptin modulates orexigenic effects of ghrelin and attenuates adiponectin and insulin levels and selectively the dark-phase feeding as revealed by central leptin gene therapy. Endocrinology 2004; 145: 4176-4184.
371. Goto M, Arima H, Watanabe M, et al. Ghrelin increases neuropeptide Y and agouti-related peptide gene expression in the arcuate Nucleus in rat hypothalamic organotypic cultures. Endocrinology 2006; 147: 5102-510.
372. Bassil AK, Dass NB, Sanger GJ. The prokinetic-like activity of ghrelin in rat isolated stomach is mediated via cholinergic and tachykininergic motor neurones. Eur J Pharmacol 2006; 544: 146-152.
373. Uno K, Katagiri H, Yamada T, et al. Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science 2006; 312: 1656-1659.
374. Bernik TR, Friedman SG, Ochani M, et,al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med 2002; 195: 781-788.
375. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-387.
376. Neschen S, Morino K, Rossbacher JC, et al. Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice. Diabetes 2006; 55:924-928.